Found 2 results
Filters: Author is Y.L. Su  [Clear All Filters]
X. L. Liu, Ren, J. K., and Su, Y. L., Association between IL-4 gene polymorphisms, IL-4 serum levels, and ankylosing spondylitis, vol. 15, no. 4, p. -, 2016.
Conflicts of interestThe authors declare no conflict of interest.REFERENCESBanchereau J, et al (2015). Generation of human B-cell lines dependent on CD40-ligation and interleukin-4. Front. Immunol. 6: 55. Baysal O, Durmuş B, Ersoy Y, Altay Z, et al (2011). Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol. Int. 31: 795-800. Bellini A, Marini MA, Bianchetti L, Barczyk M, et al (2012). Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol. 5: 140-149. Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, et al (2010). ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann. Rheum. Dis. 69: 102-107. Burton OT, Darling AR, Zhou JS, Noval-Rivas M, et al (2013). Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy. Mucosal Immunol. 6: 740-750. Chen WH, Yin HL, Lin HS, Chen CJ, et al (2011). Symptomatic noncompressive motoromyelopathy presents as early manifestation in ankylosing spondylitis. Rheumatol. Int. 31: 945-950. Costenbader KH, Gay S, Alarcón-Riquelme ME, Iaccarino L, et al (2012). Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun. Rev. 11: 604-609. Dean LE, Jones GT, MacDonald AG, Downham C, et al (2014). Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53: 650-657. Goie The HS, Steven MM, van der Linden SM, Cats A, et al (1985). Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br. J. Rheumatol. 24: 242-249. Harada Y, Tanaka S, Motomura Y, Harada Y, et al (2012). The 3′ enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T cells. Immunity 36: 188-200. Hemmerle T, Neri D, et al (2014). The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer. Int. J. Cancer 134: 467-477. Huang F, Gu J, Zhu P, Bao C, et al (2014). Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann. Rheum. Dis. 73: 587-594. Inanir A, Yigit S, Tekcan A, Tural S, et al (2013). IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol. Lett. 152: 104-108. Cortes A, Hadler J, Pointon JP, Robinson PC, International Genetics of Ankylosing Spondylitis Consortium (IGAS)Australo-Anglo-American Spondyloarthritis Consortium (TASC)Groupe Française d’Etude Génétique des Spondylarthrites (GFEGS)Nord-Trøndelag Health Study (HUNT)Spondyloarthritis Research Consortium of Canada (SPARCC)Wellcome Trust Case Control Consortium 2 (WTCCC2)et al (2013). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45: 730-738. Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, et al (2013). IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 210: 2477-2491. Jin GX, Duan JZ, Guo WL, Li L, et al (2013). Association between IL-1RN gene polymorphisms and susceptibility to ankylosing spondylitis: a large Human Genome Epidemiology review and meta-analysis. Genet. Mol. Res. 12: 1720-1730. Kassimos DG, Vassilakos J, Magiorkinis G, Garyfallos A, et al (2014). Prevalence and clinical manifestations of ankylosing spondylitis in young Greek males. Clin. Rheumatol. 33: 1303-1306. Kobak S, et al (2012). Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis. Rheumatol. Int. 32: 1785-1787. Lee SH, Lee EJ, Chung SW, Song R, et al (2013). Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker. Rheumatol. Int. 33: 1689-1692. Liang HE, Reinhardt RL, Bando JK, Sullivan BM, et al (2011). Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat. Immunol. 13: 58-66. Limón-Camacho L, Vargas-Rojas MI, Vázquez-Mellado J, Casasola-Vargas J, et al (2012). In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J. Rheumatol. 39: 830-835. Ma B, Yang B, Guo H, Wang Y, et al (2013). The association between tumor necrosis factor alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Hum. Immunol. 74: 1357-1362. Noack M, Miossec P, et al (2014). Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun. Rev. 13: 668-677. Spiess C, Bevers J3rdJackmanJ, Chiang N, et al (2013). Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokines. J. Biol. Chem. 288: 26583-26593. Suzuki A, Leland P, Joshi BH, Puri RK, et al (2015). Targeting of IL-4 and IL-13 receptors for cancer therapy. Cytokine 75: 79-88. Toellner KM, et al (2014). Cognate interactions: extrafollicular IL-4 drives germinal-center reactions, a new role for an old cytokine. Eur. J. Immunol. 44: 1917-1920. van der Heijde D, Zack D, Wajdula J, Sridharan S, et al (2014). Rates of serious infections, opportunistic infections, inflammatory bowel disease, and malignancies in subjects receiving etanercept vs. controls from clinical trials in ankylosing spondylitis: a pooled analysis. Scand. J. Rheumatol. 43: 49-53. Vijayanand P, Seumois G, Simpson LJ, Abdul-Wajid S, et al (2012). Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity 36: 175-187. Wallis SK, Cooney LA, Endres JL, Lee MJ, et al (2011). A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis. Arthritis Res. Ther. 13: R15. Wang C, Liao Q, Hu Y, Zhong D, et al (2015). T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis. Exp. Ther. Med. 9: 250-256. Wang CM, Ho HH, Chang SW, Wu YJ, et al (2012). ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res. Ther. 14: R125. Zhang L, Li YG, Li YH, Qi L, et al (2012). Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: e31000. Zhang L, Huang Y, Liu Z, Liu W, et al (2015). Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China. J. Med. Virol. 87: 1158-1167.